Professor David Nutt of Imperial College London says his research team has developed a drug that targets the brain’s neurotransmitters to mimic the effects of drinking without the risk of addiction or other negative effects.
The new drug could do for drinking what e-cigarettes have done for smoking – that is, allow people to indulge in their favorite vice without risk of addiction or other negative health effects, Professor David Nutt told BBC Today on Monday.
Nutt, a neuropsychopharmacologist at Imperial College London and former drugs advisor to the U.K. government, said the drug would be consumed as a cocktail drink and targets neurotransmitters in the brain to mimic the pleasurable effects of drunkenness, The Independent reported.
It could quickly be reversed by taking an antidote, allowing users to sober up and drive home or even return to work after a faux-boozy lunch.
more on nydailynews.com